The breast cancer patient, just 49 years old, was near death, her tumor having survived multiple kinds of chemotherapy, grown out of her chest wall, and spread to so much of her liver that she had to have half of the organ removed. But four years after she received an experimental immune-based treatment, all of her tumors have disappeared, scientists reported on Monday in Nature Medicine, and she is healthy enough to have just completed a 1,500-mile kayak trip.

Ordinarily, reports of a single patient whose advanced, almost-always-fatal cancer has seemingly been cured by an experimental therapy are as scientifically meaningful as claims of miraculous cures at Lourdes. But the National Cancer Institute researcher behind the treatment isn’t new at this, which has made scientists reluctant to dismiss the report.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy